MedQIA is an innovative, tech-based Imaging CRO specializing in providing state of the art imaging services for drug development and device trials. We bring a unique blend of superlative service for site activation and site management and our cloud based AI powered secure image management and analysis though our integrated IBIS platform. We focus on solid tumor oncology and pulmonary studies, using out proprietary image analysis software which is fully configurable, highly scalable, and accessible from anywhere. Our AI-powered image analysis and read workflows enable ultra rapid reads resulting in low adjudication rates and rapid delivery of imaging results. We offer a full range of services for Phase I - Phase IV clinical trials, working together with our Pharma and CRO partners. MedQIA is partnering with Medidata to offer our sponsors greater flexibility and the ability to maintain all of their study data in a central location.
